Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co. | 1.08% | 365.63 | 1.1% | $1192.52m | |
| JNJ | Johnson & Johnson | 0.12% | 177.22 | 0.7% | $1097.25m | |
| MRK | Merck & Co., Inc. | 0.60% | 107.46 | 0.7% | $994.87m | |
| PFE | Pfizer Inc. | 0.72% | 49.20 | 0.9% | $981.12m | |
| ABBV | AbbVie, Inc. | 0.14% | 159.61 | 1.9% | $906.78m | |
| BMY | Bristol-Myers Squibb Co. | 0.16% | 79.27 | 1.1% | $751.13m | |
| AZN | AstraZeneca Plc | 0.08% | 66.17 | 1.0% | $360.17m | |
| IDXX | IDEXX Laboratories, Inc. | -1.24% | 411.36 | 3.9% | $222.64m | |
| GSK | GSK Plc | 0.89% | 33.99 | 0.3% | $202.02m | |
| HZNP | Horizon Therapeutics Plc | 0.97% | 78.28 | 5.4% | $201.37m | |
| NVS | Novartis AG | 0.57% | 87.79 | 0.2% | $190.04m | |
| CTLT | Catalent, Inc. | -1.83% | 41.41 | 1.9% | $163.88m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 2.03% | 212.72 | 8.0% | $159.13m | |
| NVO | Novo Nordisk A/S | 0.86% | 118.84 | 0.1% | $155.62m | |
| SGEN | Seagen Inc. | -0.42% | 123.44 | 5.7% | $122.67m |
Company Profile
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses. Its clinical stage drugs include Annamycin, an Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML), and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer, and AML. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.